Thats a critical distinction, because it means these patches do not actually contain the active GLP-1 medications responsible for the weight-loss effects seen in clinical trials
It has been demonstrated that the expression of PON2 with intact lactonase activity facilitates 3OC12-HSL degradation in human airway epithelial cells and murine tracheal epithelial cells, suggesting that PON can disrupt the P
GLP-1 receptor activation exerts a chronotropic effect via the sinoatrial node
But if the weight loss includes muscle
When ERS occurs, GRP78 binds to misfolded proteins and dissociates from PERK, IRE1, and ATF6, activating downstream signaling pathways to inhibit DNA transcription and translation, prevent protein synthesis, and accelerate the degradation of aberrant proteins, thus regulating the adaptation of the intracellular environment